• SPX
  • $5,751.07
  • 0.9 %
  • $51.13
  • DJI
  • $42,352.75
  • 0.81 %
  • $341.16
  • N225
  • $38,635.62
  • 0.22 %
  • $83.56
  • FTSE
  • $8,280.63
  • -0.02 %
  • -$1.89
  • IXIC
  • $18,137.85
  • 1.22 %
  • $219.38

US Senate committee sets hearing on China's WuXi AppTec, BGI bill

By Reuters   |   Feb 26, 2024 at 07:57 PM EST
US Senate committee sets hearing on China's WuXi AppTec, BGI bill

By Karen Freifeld

(Reuters) -A U.S. Senate committee said on Monday it will hold a hearing on March 6 on a bill that would prohibit federal agencies from contracting with China's BGI, WuXi AppTec and other biotechnology companies of concern.

The bill would also stop the government from entering into contracts with companies that use the Chinese companies' equipment or services. News of the Senate bill, and similar legislation in the House, has sent shares of WuXi AppTec tumbling in recent weeks on fears it would hurt the company's large U.S. business.

The legislation is intended to prevent foreign adversaries from stealing American genetic data and personal health information, according to a statement on the U.S. Senate Homeland Security and Governmental Affairs Committee website.

The committee's hearing is a procedural step, also called a mark-up, to discuss next steps on the bill, which was sponsored by Democratic Senator Gary Peters.

A House bill introduced by Republican congressman Mike Gallagher, chair of the House select committee on China, accuses the companies of aiding Beijing's military.

WuXi AppTec has denied ties to China's military and said its business does not pose national security risks to any country.

WuXI AppTec operates in more than a half-dozen U.S. states including Pennsylvania, California and Delaware, where a subsidiary is investing some $500 million in a manufacturing facility. Two-thirds of its revenue came from the U.S. market in the first nine months of 2023, according to an investor

The company, which also has sites in Europe and China, offers a wide range of services to the pharmaceutical and healthcare industry.

BGI Group has said that statements alleging it is controlled by the Chinese government or military are false. It has said it supports protecting personal data, but that the legislation will not accomplish that goal because it "will effectively drive BGI from the U.S. market."

Earlier this month a bipartisan group of lawmakers told top Biden administration officials that the U.S. should review WuXi AppTec for sanctions.

The lawmakers told Treasury Secretary Janet Yellen, Defense Secretary Lloyd Austin and Commerce Secretary Gina Raimondo that the company's links to China's Communist Party and military threatened U.S. national security.

WuXi AppTec shares have fallen 36% in the last month.

(Reporting by Karen Freifeld in New York; Editing by Chris Sanders, Scott Malone and Matthew Lewis)

Did you find this insightful?


We are preparing, please wait

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.